Has Wame Waggenspack, MD received payments from drug or device companies?

Yes. Drug and device makers reported $81,822 in general payments to Wame Waggenspack, MD across 123 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Wame Waggenspack, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Wame Waggenspack, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Wame Waggenspack, MD

Orthopaedic Surgery · Baton Rouge, LANPI 1003834169

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (59.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Linkbio Corp at 46.8% of the total. Among orthopaedic surgery clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$81,822in general payments, 2019–2025

Across 123 payments — averaging $665.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Linkbio Corp$38K
Stryker$35K
Smith+Nephew$4K
FX Shoulder Solutions, Inc$1K
ALON Medical Technology$1K
Arthrex$618
plus $1K from 8 others

What the payments were for

Consulting fees$48,35059%
Speaking & faculty fees$3,5854%
Travel & lodging$25,34331%
Food & beverage$4,5446%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Linkbio Corp	13	$38,287
Stryker	54	$35,221
Smith+Nephew	16	$4,350
FX Shoulder Solutions, Inc	3	$1,273
ALON Medical Technology	4	$1,060
Arthrex	14	$618
Encore Medical, LP	9	$378
Integrity Orthopaedics, Inc.	2	$221
Boston Scientific	3	$135
Zimmer Biomet	1	$115
Mimedx Group, Inc.	1	$85
Heron Therapeutics, Inc.	1	$39
Ferring Pharmaceuticals Inc.	1	$21
Pacira Pharmaceuticals Incorporated	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$24,147
AEQUALIS PERFORM$24,000
AEQUALIS ASCEND FLEX$18,800
Healicoil$7,170
AEQUALIS REVERSED II$6,800
SIMPLICITI$5,200
TORNIER PERFORM REVERSED GLENOID$2,000
AEQUALIS$1,600
REUNION$842
AEQUALIS PERFORM REVERSED$400
Bone Anchors with Arthroscopic Delivery System$215
Integrity Orthopaedics$175
INSPACE$173
DJO Surgical AltiVate Anatomic System$146
DJO Surgical Match Point System$146
DJO Surgical AltiVate Reverse$146
HEALICOIL PK Shoulder$128
REGENETEN Shoulder$128
Comprehensive Primary Stem$115
EVOS$104

How this compares

$81,822 in reported general payments places this provider in the 90th percentile of 286 orthopaedic surgery providers in Louisiana.

See all orthopaedic surgery providers in Louisiana →

Medicare billing

Part B allowed, 2024

$133,030

Medicare patients

223

Services billed

1,264

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	121	$693
Ondansetron OdtOndansetron	82	$536
Methocarbamol	148	$477
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	36	$279
Tramadol Hcl	119	$278
Meloxicam	48	$108
Gabapentin	13	$70
Cephalexin	11	$23

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Baton Rouge

Christopher HarrodBaton Rouge$3M
Jorge IsazaBaton Rouge$1.2M
Kevin McCarthyBaton Rouge$594K
Robert EastonBaton Rouge$394K
Ricardo RodriguezBaton Rouge$262K
Shaun AccardoBaton Rouge$52K
Kevin RicheBaton Rouge$33K
William ShermanBaton Rouge$29K
David FerachiBaton Rouge$16K
Vinod DasaKenner$1.9M

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →